Arora, MD, S., B. Setnik, PhD, M. Drass, MD, J. D. Hudson, MD, R. Clemmer, MS, P. Meisner, PharmD, G. C. Pixton, MS, V. Goli, MD, and K. W. Sommerville, MD. “A Multicenter, 12-Month, Open-Label, Single-Arm Safety Study of Oxycodone-hydrochloride/Naltrexone-Hydrochloride Extended-Release Capsules (ALO-02) in Patients With Moderate-to-Severe Chronic Noncancer Pain”. Journal of Opioid Management, vol. 10, no. 6, Nov. 2014, pp. 423-36, doi:10.5055/jom.2014.0239.